home / stock / nbrv / nbrv news


NBRV News and Press, Nabriva Therapeutics plc From 03/13/20

Stock Information

Company Name: Nabriva Therapeutics plc
Stock Symbol: NBRV
Market: NASDAQ

Menu

NBRV NBRV Quote NBRV Short NBRV News NBRV Articles NBRV Message Board
Get NBRV Alerts

News, Short Squeeze, Breakout and More Instantly...

NBRV - Nabriva Therapeutics plc 2019 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Nabriva Therapeutics plc in conjunction with their 2019 Q4 earnings Read more ...

NBRV - SOHO, TLRY, CPLG and BLCM among midday movers

Gainers:  Champions Oncology (NASDAQ: CSBR ) +38% . More news on: Champions Oncology, Inc., PFSweb, Inc., Mayville Engineering Company, Inc., Stocks on the move, , Read more ...

NBRV - Healthcare stocks dominate premarket losers

Zuora (NYSE: ZUO )  -18%  on Q4 earnings . More news on: Zuora, Inc., Tiziana Life Sciences PLC, Aytu BioScience, Inc., Stocks on the move, , Read more ...

NBRV - Nabriva Therapeutics' (NBRV) CEO Ted Schroeder on Q4 2019 Results - Earnings Call Transcript

Nabriva Therapeutics PLC (NBRV) Q4 2019 Earnings Conference Call March 12, 2020 4:30 PM ET Company Participants Gary Sender – Chief Financial Officer Ted Schroeder – Chief Executive Officer Francesco Maria Lavino – Chief Commercial Officer Steve Gelone ...

NBRV - Nabriva Therapeutics EPS beats by $0.05, misses on revenue

Nabriva Therapeutics (NASDAQ: NBRV ): Q4 GAAP EPS of -$0.29 beats by $0.05 . More news on: Nabriva Therapeutics plc, Earnings news and commentary, Healthcare stocks news, , Read more ...

NBRV - Nabriva Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results and Recent Corporate Highlights

- Prioritizing community opportunity for oral XENLETA given broad reimbursement coverage- - Reducing balance sheet risk through early paydown of a substantial portion of Hercules loan- - Pursuing options to provide lefamulin to patients with coronavirus with secondary bacterial infec...

NBRV - Nabriva Therapeutics to Report 2019 Financial Results and Recent Corporate Highlights on March 12, 2020

DUBLIN, Ireland, March 10, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it will report its fourth quarter a...

NBRV - Tech Majors, Boeing, UPS And Tesla On Tap

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

NBRV - Vaccinex joins coronavirus-stoked rally, up 39%

Ultra-thinly traded micro cap Vaccinex ( VCNX +39% ) jumps on a 29x surge in volume, a modest 152K shares, apparently joining the coronavirus rally. More news on: Vaccinex, Inc., NanoViricides, Inc., Moderna, Inc., Healthcare stocks news, Stocks on the move, Read more ...

NBRV - Respiratory virus in China less virulent than 2003 SARS

The WSJ reports that the coronavirus responsible for the current outbreak in China, mainly in the city of Wuhan, appears less virulent than the virus responsible for the SARS outbreak in 2003. More news on: Moderna, Inc., NanoViricides, Inc., Novavax, Inc., Healthcare stocks news, Stocks...

Previous 10 Next 10